ABSTRACT
Ischemic heart disease (IHD) is a leading cause of mortality and stable angina represents the most frequent clinical presentation (Gibbons et al. 2003). Besides being associated with high morbidity and mortality, angina symptoms are also well known to be associated with depression and poor quality of life (Rumsfeld et al. 2003). Antianginal treatment has not been shown to modify the natural history of disease. Therefore, the primary goal in the management of such patients is symptom control and amelioration of quality of life. Revascularization by means of coronary artery bypass graft (CABG) surgery or percutaneous coronary intervention (PCI), drug therapy and a various combination of such options represent the available treatment strategies for patients with stable coronary artery disease (CAD).
